Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD

This study was designed to further characterize peripheral skeletal muscle alterations in patients with chronic obstructive pulmonary disease (COPD) and to evaluate the possible relationship between myosin heavy chain (MyoHC) isoform expression and exercise tolerance in these individuals. MyoHC composition from biopsy of the vastus lateralis muscle was examined in 12 COPD patients (forced expiratory volume in one second (FEV1)=31+/-9% predicted, peak oxygen consumption (V'O2)=15+/-4 mL x kg(-1) x min(-1)) and 10 age-matched normal male subjects (peak V'O2=20+/-5 mL x kg(-1) x min(-1)). The proportion of MyoHC type I was smaller in COPD than in normals (27+/-17% versus 41+/-9%, p<0.05) with an increase in MyoHC type IIa (51+/-15% versus 39+/-9%, p<0.05) and the proportion of MyoHC type IIx being comparable between both groups. A significant relationship was found between peak V'Oo2 mL x kg(-1) x min(-1) and FEV1 % pred (r=0.91, p<0.0001) and the percentage of MyoHC type I (r=0.61, p=0.016). In stepwise multiple regression, only FEV1 % pred was found to be a significant determinant of peak V'O2 (p<0.0001). This variable explained 83% of the total variance of peak V'O2. In summary, this study showed considerable modifications in the phenotypic expression of the myosin heavy chain in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. An independent effect of myosin heavy chain expression on exercise capacity was not found. These results suggest that chronic inactivity and muscle deconditioning may not be the sole factors explaining peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease.

This article has been cited by other articles:

				R. Debigare and F. Maltais The major limitation to exercise performance in COPD is lower limb muscle dysfunction J Appl Physiol, August 1, 2008; 105(2): 751 - 753. [Full Text] [PDF]

				H. J. Green, M. Burnett, T. A. Duhamel, C. D'Arsigny, D. E. O'Donnell, K. A. Webb, and J. Ouyang Abnormal sarcoplasmic reticulum Ca2+-sequestering properties in skeletal muscle in chronic obstructive pulmonary disease Am J Physiol Cell Physiol, August 1, 2008; 295(2): C350 - C357. [Abstract] [Full Text] [PDF]

				H. R Gosker, M. P Zeegers, E. F M Wouters, and A. M W J Schols Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis Thorax, November 1, 2007; 62(11): 944 - 949. [Abstract] [Full Text] [PDF]

				C. A. C. Ottenheijm, L. M. A. Heunks, and P. N. R. Dekhuijzen Diaphragm Muscle Fiber Dysfunction in Chronic Obstructive Pulmonary Disease: Toward a Pathophysiological Concept Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1233 - 1240. [Abstract] [Full Text] [PDF]

				S. Radom-Aizik, N. Kaminski, S. Hayek, H. Halkin, D. M. Cooper, and I. Ben-Dov Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease J Appl Physiol, May 1, 2007; 102(5): 1976 - 1984. [Abstract] [Full Text] [PDF]

				S. Jelic and T. H. Le Jemtel Diagnostic Usefulness of B-Type Natriuretic Peptide and Functional Consequences of Muscle Alterations in COPD and Chronic Heart Failure. Chest, October 1, 2006; 130(4): 1220 - 1230. [Abstract] [Full Text] [PDF]

				L. Nici, C. Donner, E. Wouters, R. Zuwallack, N. Ambrosino, J. Bourbeau, M. Carone, B. Celli, M. Engelen, B. Fahy, et al. American thoracic society/european respiratory society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1390 - 1413. [Full Text] [PDF]

				H. R. Gosker, P. Schrauwen, R. Broekhuizen, M. K. C. Hesselink, E. Moonen-Kornips, K. A. Ward, F. M. E. Franssen, E. F. M. Wouters, and A. M. W. J. Schols Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E976 - E981. [Abstract] [Full Text] [PDF]

				I. Vogiatzis, G. Terzis, S. Nanas, G. Stratakos, D. C. M. Simoes, O. Georgiadou, S. Zakynthinos, and C. Roussos Skeletal Muscle Adaptations to Interval Training in Patients With Advanced COPD Chest, December 1, 2005; 128(6): 3838 - 3845. [Abstract] [Full Text] [PDF]

				A. Couillard and C. Prefaut From muscle disuse to myopathy in COPD: potential contribution of oxidative stress Eur. Respir. J., October 1, 2005; 26(4): 703 - 719. [Abstract] [Full Text] [PDF]

				W D-C Man, N S Hopkinson, F Harraf, D Nikoletou, M I Polkey, and J Moxham Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease Thorax, September 1, 2005; 60(9): 718 - 722. [Abstract] [Full Text] [PDF]

				T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38. [Full Text] [PDF]

				J. P Mattson and J. C Martin Emphysema-induced reductions in locomotory skeletal muscle contractile function Exp Physiol, July 1, 2005; 90(4): 519 - 525. [Abstract] [Full Text] [PDF]

				M. Hayot, A. Michaud, C. Koechlin, M-A. Caron, P. LeBlanc, C. Prefaut, and F. Maltais Skeletal muscle microbiopsy: a validation study of a minimally invasive technique Eur. Respir. J., March 1, 2005; 25(3): 431 - 440. [Abstract] [Full Text] [PDF]

				S. W. Jones, D. J. Baker, S. M. Gardiner, T. Bennett, J. A. Timmons, and P. L. Greenhaff The Effect of the {beta}2-Adrenoceptor Agonist Prodrug BRL-47672 on Cardiovascular Function, Skeletal Muscle Myosin Heavy Chain, and MyoD Expression in the Rat J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1225 - 1231. [Abstract] [Full Text] [PDF]

				C. Coronell, M. Orozco-Levi, R. Mendez, A. Ramirez-Sarmiento, J.B. Galdiz, and J. Gea Relevance of assessing quadriceps endurance in patients with COPD Eur. Respir. J., July 1, 2004; 24(1): 129 - 136. [Abstract] [Full Text] [PDF]

				J.P. Mattson, M.D. Delp, and D.C. Poole Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters Eur. Respir. J., May 1, 2004; 23(5): 703 - 707. [Abstract] [Full Text] [PDF]

				M.P.K.J. Engelen, M. Orozco-Levi, N.E.P. Deutz, E. Barreiro, N. Hernandez, E.F.M. Wouters, J. Gea, and A.M.W.J. Schols Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2004; 23(4): 545 - 551. [Abstract] [Full Text] [PDF]

				R. S. Richardson, B. T. Leek, T. P. Gavin, L. J. Haseler, S. R. D. Mudaliar, R. Henry, O. Mathieu-Costello, and P. D. Wagner Reduced Mechanical Efficiency in Chronic Obstructive Pulmonary Disease but Normal Peak VO2 with Small Muscle Mass Exercise Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 89 - 96. [Abstract] [Full Text] [PDF]

				M. J. Mador, O. Deniz, A. Aggarwal, and T. J. Kufel Quadriceps Fatigability after Single Muscle Exercise in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 102 - 108. [Abstract] [Full Text] [PDF]

				M. J. Mador, E. Bozkanat, and T. J. Kufel Quadriceps Fatigue After Cycle Exercise in Patients With COPD Compared With Healthy Control Subjects Chest, April 1, 2003; 123(4): 1104 - 1111. [Abstract] [Full Text] [PDF]

				A. Couillard, C. Koechlin, J.P. Cristol, A. Varray, and C. Prefaut Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients Eur. Respir. J., November 1, 2002; 20(5): 1123 - 1129. [Abstract] [Full Text] [PDF]

				P Hawkins, L C Johnson, D Nikoletou, C-H Hamnegard, R Sherwood, M I Polkey, and J Moxham Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease Thorax, October 1, 2002; 57(10): 853 - 859. [Abstract] [Full Text] [PDF]

				H.R. Gosker, H. van Mameren, P.J. van Dijk, M.P.K.J. Engelen, G.J. van der Vusse, E.F.M. Wouters, and A.M.W.J. Schols Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2002; 19(4): 617 - 625. [Abstract] [Full Text] [PDF]

				R. DEBIGARE, C. H. COTE, and F. MALTAIS Peripheral Muscle Wasting in Chronic Obstructive Pulmonary Disease . Clinical Relevance and Mechanisms Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1712 - 1717. [Full Text] [PDF]

				T. L. Clanton and P. F. Klawitter Physiological and Genomic Consequences of Intermittent Hypoxia: Invited Review: Adaptive responses of skeletal muscle to intermittent hypoxia: the known and the unknown J Appl Physiol, June 1, 2001; 90(6): 2476 - 2487. [Abstract] [Full Text] [PDF]

				M. Yoshikawa, T. Yoneda, H. Takenaka, A. Fukuoka, Y. Okamoto, N. Narita, and K. Nezu Distribution of Muscle Mass and Maximal Exercise Performance in Patients With COPD Chest, January 1, 2001; 119(1): 93 - 98. [Abstract] [Full Text] [PDF]

				F. Maltais, P. LeBlanc, F. Whittom, C. Simard, K. Marquis, M. Bélanger, M.-J. Breton, and J. Jobin Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD Thorax, October 1, 2000; 55(10): 848 - 853. [Abstract] [Full Text]

				P. J. Barnes Chronic Obstructive Pulmonary Disease N. Engl. J. Med., July 27, 2000; 343(4): 269 - 280. [Full Text] [PDF]

				H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047. [Abstract] [Full Text] [PDF]